Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Scholar Rock Holding Corp
(NQ:
SRRK
)
9.320
-0.060 (-0.64%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Scholar Rock Holding Corp
< Previous
1
2
3
4
5
6
7
Next >
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Today 16:15 EDT
From
Scholar Rock
Via
Business Wire
SRRK Stock Earnings: Scholar Rock Holding Beats EPS for Q2 2024
August 08, 2024
SRRK stock results show that Scholar Rock Holding beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Scholar Rock Reports Second Quarter 2024 Financial Results and Highlights Business Progress
August 08, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock to Host Conference Call to Discuss Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024
July 23, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 12, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Announces New SRK-439 Preclinical Data Showing Significant Lean Mass Preservation and Attenuation of Fat Mass Rebound Following GLP-1 Receptor Agonist Withdrawal
June 24, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 18, 2024
From
Scholar Rock
Via
Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
June 03, 2024
Via
Benzinga
Scholar Rock Presents New Data from SRK-181 Phase 1 DRAGON Trial at ASCO 2024 Annual Meeting
June 03, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock to Present New Data from SRK-181 Phase 1 DRAGON Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting
May 28, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Announces Initiation of Phase 2 EMBRAZE Trial of Apitegromab in Obesity and New Preclinical Data Supporting SRK-439 in Obesity
May 22, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock to Participate in Upcoming Investor Conferences
May 20, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 17, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock to Host Investor Day on May 22, 2024
May 14, 2024
From
Scholar Rock
Via
Business Wire
SRRK Stock Earnings: Scholar Rock Holding Misses EPS for Q1 2024
May 07, 2024
SRRK stock results show that Scholar Rock Holding missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Scholar Rock Reports First Quarter 2024 Financial Results and Highlights Business Progress
May 07, 2024
From
Scholar Rock
Via
Business Wire
3 Speculative Weight Loss Drug Stocks to Bet On for Big Gains
April 24, 2024
These weight loss drug stocks are relatively unknown and brimming with potential following the massive success of Novo Nordisk and Eli Lilly.
Via
InvestorPlace
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 12, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Is A Potential M&A Target, Its Exploration of Obesity Market Garners Interest: Analyst
March 28, 2024
Raymond James has initiated coverage on Scholar Rock Holding (NASDAQ:SRRK), supported by the potential value with a couple of key programs utilizing selective myostatin inhibition to
Via
Benzinga
SRRK Stock Earnings: Scholar Rock Holding Misses EPS for Q4 2023
March 19, 2024
SRRK stock results show that Scholar Rock Holding missed analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Scholar Rock Reports Full Year 2023 Financial Results and Highlights Business Progress
March 19, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 15, 2024
From
Scholar Rock, Inc.
Via
Business Wire
NIO Reports Upbeat Earnings, Joins Dave, V2X, Riskified And Other Big Stocks Moving Higher On Tuesday
March 05, 2024
U.S. stocks were lower, with the Dow Jones index falling more than 200 points on Tuesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Scholar Rock to Participate in Upcoming Investor Conferences
February 28, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 16, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Announces the Addition of Katie Peng to Its Board of Directors and Promotes Mo Qatanani, Ph.D. to Chief Scientific Officer
February 15, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Presents New Preclinical Data Demonstrating Potential Benefit of SRK-439 for Healthy Weight Loss Management
February 06, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Announces Presentation of New Preclinical Data Evaluating SRK-439 in Obesity at Keystone Symposia
January 25, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Announces FDA Clearance of IND Application to Initiate Phase 2 Proof-of-Concept Trial with Apitegromab to Treat Obesity
January 23, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 12, 2024
From
Scholar Rock
Via
Business Wire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.